Screener
Achieve Life Sciences ACHV EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Achieve Life Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218177
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Total other income | 295 | 67 |
| Net loss | $(10,168) | $(12,827) |
| OTHER COMPREHENSIVE LOSS | ||
| Net unrealized loss on marketable securities | (8) | (25) |
| Total other comprehensive loss | (8) | (25) |
| Comprehensive loss | $(10,176) | $(12,852) |
| Basic and diluted net loss per common share [note 7[d]] | $(0.19) | $(0.37) |
| Weighted average shares used in computation of basic and diluted net loss per common share [note 7[d]] | 53,381,989 | 34,685,072 |
Item 1. Consolidated Financial Statements
FAQ
- What is Achieve Life Sciences's EPS (diluted)?
- Achieve Life Sciences (ACHV) reported EPS (diluted) of -$0.19 in Q1 2026.
- How has Achieve Life Sciences's EPS (diluted) changed year-over-year?
- Achieve Life Sciences's EPS (diluted) increased by 48.6% year-over-year, from -$0.37 to -$0.19.
- What is the long-term trend for Achieve Life Sciences's EPS (diluted)?
- Over 4 years (2021 to 2025), Achieve Life Sciences's EPS (diluted) has grown at a -26.1% compound annual growth rate (CAGR), from -$4.30 to -$1.28.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Achieve Life Sciences's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude